Qiagen Draws Early Takeover Interest From EQT, Advent

Qiagen NV, a European molecular testing company, has drawn takeover interest from EQT AB and Advent, Bloomberg reported. The two firms are among parties evaluating potential acquisitions of the company. No offers or negotiations have been announced by Qiagen or the interested parties.

Next story